Yong-Moon Park
Concepts (254)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Obesity | 29 | 2023 | 1202 | 5.340 |
Why?
| Diet, Mediterranean | 8 | 2023 | 12 | 4.420 |
Why?
| Nutrition Surveys | 28 | 2023 | 122 | 4.210 |
Why?
| Diabetes Mellitus, Type 2 | 17 | 2023 | 486 | 3.840 |
Why?
| Breast Neoplasms | 12 | 2024 | 1248 | 3.390 |
Why?
| Insulin Resistance | 13 | 2018 | 300 | 3.080 |
Why?
| Republic of Korea | 34 | 2023 | 49 | 2.940 |
Why?
| Hypertension | 11 | 2023 | 564 | 2.840 |
Why?
| Body Mass Index | 28 | 2022 | 712 | 2.440 |
Why?
| Blood Glucose | 14 | 2022 | 489 | 2.410 |
Why?
| Risk Factors | 45 | 2024 | 3931 | 2.170 |
Why?
| Cardiovascular Diseases | 12 | 2022 | 476 | 1.960 |
Why?
| Diet | 10 | 2023 | 598 | 1.950 |
Why?
| Middle Aged | 62 | 2022 | 13072 | 1.730 |
Why?
| Female | 80 | 2024 | 28410 | 1.670 |
Why?
| Overweight | 6 | 2019 | 240 | 1.630 |
Why?
| Inflammation | 4 | 2022 | 674 | 1.610 |
Why?
| Adult | 55 | 2023 | 14191 | 1.500 |
Why?
| Siblings | 3 | 2021 | 37 | 1.490 |
Why?
| Triglycerides | 7 | 2020 | 195 | 1.480 |
Why?
| Metformin | 2 | 2021 | 66 | 1.470 |
Why?
| Prospective Studies | 21 | 2023 | 2603 | 1.440 |
Why?
| Humans | 93 | 2024 | 54205 | 1.370 |
Why?
| Cross-Sectional Studies | 21 | 2023 | 1692 | 1.360 |
Why?
| Health Surveys | 7 | 2020 | 262 | 1.320 |
Why?
| Diabetes Mellitus | 7 | 2023 | 309 | 1.300 |
Why?
| F2-Isoprostanes | 4 | 2023 | 8 | 1.290 |
Why?
| Postmenopause | 6 | 2022 | 102 | 1.280 |
Why?
| Feeding Behavior | 5 | 2022 | 200 | 1.260 |
Why?
| Aged | 39 | 2023 | 10042 | 1.180 |
Why?
| Blood Pressure | 12 | 2020 | 587 | 1.140 |
Why?
| Waist Circumference | 11 | 2020 | 20 | 1.060 |
Why?
| Aging | 5 | 2022 | 784 | 1.050 |
Why?
| Prevalence | 15 | 2023 | 1024 | 1.050 |
Why?
| Male | 55 | 2023 | 27311 | 1.030 |
Why?
| Proportional Hazards Models | 12 | 2022 | 429 | 0.970 |
Why?
| Esophageal Neoplasms | 2 | 2022 | 100 | 0.970 |
Why?
| Oxidative Stress | 5 | 2023 | 958 | 0.960 |
Why?
| Cataract | 2 | 2015 | 46 | 0.950 |
Why?
| Premenopause | 6 | 2018 | 26 | 0.940 |
Why?
| Isoprostanes | 1 | 2022 | 3 | 0.860 |
Why?
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 231 | 0.830 |
Why?
| Periodontitis | 3 | 2019 | 10 | 0.810 |
Why?
| United States | 19 | 2023 | 5196 | 0.800 |
Why?
| Cholesterol | 7 | 2021 | 155 | 0.800 |
Why?
| Hypoglycemia | 5 | 2022 | 61 | 0.790 |
Why?
| Atrial Fibrillation | 1 | 2024 | 197 | 0.790 |
Why?
| Young Adult | 14 | 2020 | 4317 | 0.780 |
Why?
| Diabetes, Gestational | 2 | 2022 | 54 | 0.760 |
Why?
| Cholesterol, HDL | 8 | 2021 | 42 | 0.750 |
Why?
| Body Weight | 5 | 2019 | 578 | 0.750 |
Why?
| Age Factors | 6 | 2020 | 1198 | 0.720 |
Why?
| Risk Assessment | 4 | 2019 | 1360 | 0.670 |
Why?
| Incidence | 12 | 2024 | 1082 | 0.670 |
Why?
| Acidosis | 1 | 2018 | 38 | 0.670 |
Why?
| Phenotype | 6 | 2023 | 820 | 0.670 |
Why?
| Neoplasms | 3 | 2022 | 1316 | 0.660 |
Why?
| Follow-Up Studies | 13 | 2021 | 2386 | 0.650 |
Why?
| Adenocarcinoma | 1 | 2022 | 428 | 0.650 |
Why?
| Cohort Studies | 18 | 2022 | 1543 | 0.650 |
Why?
| Physical Fitness | 2 | 2015 | 69 | 0.630 |
Why?
| Intraocular Pressure | 2 | 2016 | 89 | 0.630 |
Why?
| Odds Ratio | 6 | 2018 | 602 | 0.620 |
Why?
| Plaque, Atherosclerotic | 1 | 2018 | 47 | 0.620 |
Why?
| Diabetic Angiopathies | 2 | 2018 | 21 | 0.610 |
Why?
| Hypertriglyceridemia | 2 | 2014 | 17 | 0.590 |
Why?
| Coronary Artery Disease | 2 | 2018 | 329 | 0.580 |
Why?
| Breast Feeding | 1 | 2018 | 189 | 0.580 |
Why?
| Alanine Transaminase | 2 | 2014 | 151 | 0.580 |
Why?
| Glaucoma, Open-Angle | 1 | 2016 | 25 | 0.580 |
Why?
| Insulin | 2 | 2018 | 510 | 0.550 |
Why?
| Ideal Body Weight | 1 | 2015 | 7 | 0.530 |
Why?
| Nutrition Assessment | 4 | 2021 | 80 | 0.530 |
Why?
| Aged, 80 and over | 9 | 2018 | 3430 | 0.530 |
Why?
| Muscles | 1 | 2015 | 114 | 0.520 |
Why?
| Lipoproteins | 1 | 2015 | 45 | 0.520 |
Why?
| Lipids | 2 | 2015 | 178 | 0.520 |
Why?
| Zinc | 1 | 2015 | 59 | 0.510 |
Why?
| Energy Metabolism | 1 | 2017 | 311 | 0.500 |
Why?
| Metabolic Diseases | 1 | 2015 | 44 | 0.500 |
Why?
| Antihypertensive Agents | 2 | 2012 | 139 | 0.480 |
Why?
| Diabetic Retinopathy | 1 | 2014 | 41 | 0.470 |
Why?
| Body Composition | 1 | 2015 | 349 | 0.450 |
Why?
| Sarcopenia | 1 | 2014 | 83 | 0.450 |
Why?
| Sex Factors | 6 | 2017 | 766 | 0.440 |
Why?
| Bipolar Disorder | 1 | 2014 | 209 | 0.440 |
Why?
| Ferritins | 1 | 2012 | 31 | 0.430 |
Why?
| Depressive Disorder, Major | 1 | 2014 | 159 | 0.430 |
Why?
| Menopause | 1 | 2013 | 61 | 0.420 |
Why?
| Dinoprost | 3 | 2022 | 12 | 0.410 |
Why?
| Fasting | 3 | 2018 | 76 | 0.400 |
Why?
| Adipose Tissue | 1 | 2013 | 207 | 0.400 |
Why?
| Diabetes Complications | 1 | 2012 | 123 | 0.400 |
Why?
| Socioeconomic Factors | 4 | 2018 | 640 | 0.400 |
Why?
| Prognosis | 8 | 2021 | 2118 | 0.400 |
Why?
| Health Knowledge, Attitudes, Practice | 2 | 2012 | 541 | 0.380 |
Why?
| Stroke | 4 | 2020 | 526 | 0.370 |
Why?
| Comorbidity | 3 | 2018 | 662 | 0.350 |
Why?
| Anti-Mullerian Hormone | 1 | 2018 | 5 | 0.340 |
Why?
| Meat | 2 | 2019 | 59 | 0.340 |
Why?
| Hypoglycemic Agents | 2 | 2021 | 177 | 0.330 |
Why?
| Dietary Fats | 1 | 2018 | 142 | 0.310 |
Why?
| Glucose Intolerance | 2 | 2019 | 28 | 0.310 |
Why?
| Sex Distribution | 4 | 2015 | 158 | 0.300 |
Why?
| Medicaid | 3 | 2014 | 267 | 0.290 |
Why?
| Myocardial Infarction | 3 | 2020 | 423 | 0.290 |
Why?
| Colorectal Neoplasms | 2 | 2020 | 236 | 0.290 |
Why?
| Obesity, Abdominal | 3 | 2022 | 12 | 0.290 |
Why?
| Cardiovascular System | 2 | 2018 | 50 | 0.270 |
Why?
| Retrospective Studies | 10 | 2022 | 6429 | 0.270 |
Why?
| Energy Intake | 2 | 2022 | 196 | 0.270 |
Why?
| Autonomic Nervous System | 2 | 2018 | 75 | 0.260 |
Why?
| Exercise | 4 | 2022 | 552 | 0.250 |
Why?
| Case-Control Studies | 3 | 2021 | 1228 | 0.250 |
Why?
| Anthracyclines | 1 | 2024 | 25 | 0.240 |
Why?
| Income | 2 | 2015 | 102 | 0.240 |
Why?
| Logistic Models | 3 | 2018 | 992 | 0.240 |
Why?
| Receptors, Estrogen | 2 | 2021 | 131 | 0.230 |
Why?
| Cause of Death | 2 | 2022 | 165 | 0.230 |
Why?
| Educational Status | 2 | 2015 | 260 | 0.230 |
Why?
| Cooking | 2 | 2019 | 19 | 0.220 |
Why?
| Survivors | 1 | 2024 | 137 | 0.220 |
Why?
| Antibodies, Bacterial | 2 | 2019 | 38 | 0.220 |
Why?
| Health Status | 2 | 2015 | 368 | 0.210 |
Why?
| Lutein | 1 | 2022 | 10 | 0.210 |
Why?
| beta Carotene | 1 | 2022 | 15 | 0.210 |
Why?
| Nutritional Physiological Phenomena | 1 | 2022 | 22 | 0.210 |
Why?
| Adolescent | 6 | 2023 | 6890 | 0.210 |
Why?
| Laryngeal Neoplasms | 1 | 2022 | 55 | 0.210 |
Why?
| ROC Curve | 2 | 2014 | 259 | 0.200 |
Why?
| Carotenoids | 1 | 2022 | 46 | 0.200 |
Why?
| Plant Proteins | 1 | 2022 | 72 | 0.200 |
Why?
| Time Factors | 5 | 2020 | 3209 | 0.200 |
Why?
| Korea | 3 | 2023 | 5 | 0.200 |
Why?
| Risk | 2 | 2019 | 343 | 0.190 |
Why?
| Sleep | 2 | 2021 | 188 | 0.180 |
Why?
| Survival Rate | 3 | 2020 | 951 | 0.180 |
Why?
| Cardiac Surgical Procedures | 2 | 2013 | 318 | 0.180 |
Why?
| Breakfast | 1 | 2019 | 16 | 0.170 |
Why?
| Sleep Initiation and Maintenance Disorders | 1 | 2019 | 43 | 0.170 |
Why?
| Hyperglycemia | 1 | 2019 | 84 | 0.170 |
Why?
| Hydrogen-Ion Concentration | 1 | 2018 | 194 | 0.170 |
Why?
| Parkinson Disease | 1 | 2021 | 180 | 0.160 |
Why?
| Vegetables | 1 | 2018 | 74 | 0.160 |
Why?
| Epigenesis, Genetic | 1 | 2022 | 399 | 0.160 |
Why?
| Mouth | 1 | 2018 | 35 | 0.160 |
Why?
| Glycemic Index | 1 | 2018 | 5 | 0.160 |
Why?
| Rural Population | 3 | 2013 | 597 | 0.160 |
Why?
| Periodontal Index | 2 | 2016 | 9 | 0.160 |
Why?
| Child | 4 | 2014 | 7340 | 0.160 |
Why?
| Carcinoma, Hepatocellular | 1 | 2020 | 203 | 0.160 |
Why?
| Diabetic Neuropathies | 1 | 2018 | 55 | 0.160 |
Why?
| South Carolina | 2 | 2014 | 42 | 0.160 |
Why?
| Hypercholesterolemia | 1 | 2017 | 42 | 0.150 |
Why?
| Cluster Analysis | 1 | 2018 | 249 | 0.150 |
Why?
| Fruit | 1 | 2018 | 143 | 0.150 |
Why?
| Waist-Hip Ratio | 1 | 2017 | 8 | 0.150 |
Why?
| Tonometry, Ocular | 1 | 2016 | 14 | 0.150 |
Why?
| Dementia | 1 | 2018 | 149 | 0.150 |
Why?
| Stomach Neoplasms | 1 | 2020 | 173 | 0.150 |
Why?
| Brain Ischemia | 1 | 2018 | 169 | 0.140 |
Why?
| Liver Neoplasms | 1 | 2020 | 352 | 0.140 |
Why?
| Anthropometry | 1 | 2016 | 96 | 0.140 |
Why?
| C-Reactive Protein | 1 | 2016 | 159 | 0.130 |
Why?
| Blepharoptosis | 1 | 2015 | 15 | 0.130 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 231 | 0.130 |
Why?
| Alcohol Drinking | 2 | 2015 | 259 | 0.130 |
Why?
| Adrenergic Uptake Inhibitors | 1 | 2014 | 17 | 0.130 |
Why?
| Texas | 1 | 2015 | 160 | 0.130 |
Why?
| Reference Values | 1 | 2015 | 354 | 0.130 |
Why?
| Conduct Disorder | 1 | 2014 | 17 | 0.130 |
Why?
| Patient Compliance | 1 | 2016 | 247 | 0.130 |
Why?
| Age Distribution | 1 | 2015 | 198 | 0.130 |
Why?
| Myopia | 1 | 2014 | 8 | 0.120 |
Why?
| Food Supply | 1 | 2015 | 99 | 0.120 |
Why?
| Toothbrushing | 1 | 2013 | 2 | 0.120 |
Why?
| Neoplasm Staging | 1 | 2017 | 806 | 0.120 |
Why?
| Social Class | 1 | 2015 | 109 | 0.120 |
Why?
| Linear Models | 1 | 2015 | 308 | 0.120 |
Why?
| Health Status Indicators | 1 | 2014 | 94 | 0.120 |
Why?
| Exercise Test | 1 | 2014 | 151 | 0.120 |
Why?
| Asthma | 1 | 2017 | 293 | 0.120 |
Why?
| Anxiety Disorders | 1 | 2014 | 138 | 0.120 |
Why?
| Metabolome | 1 | 2015 | 109 | 0.120 |
Why?
| Pregnancy | 2 | 2022 | 2618 | 0.120 |
Why?
| Metabolomics | 1 | 2015 | 149 | 0.120 |
Why?
| Vitamin D Deficiency | 1 | 2014 | 53 | 0.120 |
Why?
| Vitamin D | 1 | 2014 | 101 | 0.120 |
Why?
| Organ Size | 1 | 2014 | 237 | 0.120 |
Why?
| Ibuprofen | 1 | 2013 | 28 | 0.120 |
Why?
| Analysis of Variance | 1 | 2015 | 634 | 0.110 |
Why?
| Anti-Arrhythmia Agents | 1 | 2013 | 87 | 0.110 |
Why?
| Ductus Arteriosus, Patent | 1 | 2013 | 37 | 0.110 |
Why?
| Voluntary Health Agencies | 1 | 2012 | 5 | 0.110 |
Why?
| International Agencies | 1 | 2012 | 14 | 0.110 |
Why?
| Tachycardia, Supraventricular | 1 | 2013 | 39 | 0.110 |
Why?
| Heart Septal Defects, Atrial | 1 | 2013 | 45 | 0.110 |
Why?
| Leukocyte Count | 1 | 2013 | 77 | 0.110 |
Why?
| Sex Characteristics | 2 | 2015 | 214 | 0.110 |
Why?
| Albuminuria | 1 | 2012 | 42 | 0.110 |
Why?
| Cardiovascular Agents | 1 | 2013 | 60 | 0.110 |
Why?
| Smoking | 2 | 2015 | 555 | 0.110 |
Why?
| Absorptiometry, Photon | 1 | 2013 | 174 | 0.110 |
Why?
| Awareness | 1 | 2012 | 32 | 0.110 |
Why?
| Central Nervous System Stimulants | 1 | 2014 | 255 | 0.100 |
Why?
| Catheter Ablation | 1 | 2013 | 131 | 0.100 |
Why?
| Sensitivity and Specificity | 1 | 2014 | 922 | 0.100 |
Why?
| Disease Management | 1 | 2013 | 184 | 0.100 |
Why?
| Needs Assessment | 1 | 2012 | 153 | 0.100 |
Why?
| Down-Regulation | 1 | 2012 | 388 | 0.100 |
Why?
| Severity of Illness Index | 3 | 2020 | 1081 | 0.100 |
Why?
| Diet Surveys | 2 | 2022 | 34 | 0.100 |
Why?
| Longitudinal Studies | 3 | 2022 | 740 | 0.090 |
Why?
| Puerto Rico | 2 | 2019 | 17 | 0.090 |
Why?
| Practice Guidelines as Topic | 1 | 2012 | 489 | 0.090 |
Why?
| Muscle, Skeletal | 1 | 2014 | 846 | 0.080 |
Why?
| Heart Defects, Congenital | 1 | 2013 | 608 | 0.070 |
Why?
| Multivariate Analysis | 2 | 2020 | 643 | 0.070 |
Why?
| Life Style | 2 | 2022 | 156 | 0.070 |
Why?
| Databases, Factual | 2 | 2019 | 683 | 0.070 |
Why?
| National Health Programs | 1 | 2023 | 17 | 0.060 |
Why?
| Predictive Value of Tests | 2 | 2017 | 1045 | 0.050 |
Why?
| Diet, Vegetarian | 1 | 2022 | 6 | 0.050 |
Why?
| Thinness | 1 | 2022 | 57 | 0.050 |
Why?
| Longevity | 1 | 2022 | 87 | 0.050 |
Why?
| Mortality | 1 | 2021 | 102 | 0.050 |
Why?
| Echocardiography | 2 | 2013 | 392 | 0.050 |
Why?
| Actinomyces | 1 | 2019 | 9 | 0.050 |
Why?
| Poultry | 1 | 2019 | 29 | 0.040 |
Why?
| Receptors, Progesterone | 1 | 2019 | 57 | 0.040 |
Why?
| Receptor, erbB-2 | 1 | 2019 | 79 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2023 | 1301 | 0.040 |
Why?
| Reflex | 1 | 2018 | 33 | 0.040 |
Why?
| Biometry | 1 | 2017 | 28 | 0.040 |
Why?
| DNA Methylation | 1 | 2022 | 574 | 0.040 |
Why?
| Dietary Carbohydrates | 1 | 2018 | 89 | 0.040 |
Why?
| Hemodynamics | 1 | 2018 | 290 | 0.040 |
Why?
| Survival Analysis | 1 | 2018 | 735 | 0.040 |
Why?
| Disease Progression | 1 | 2018 | 913 | 0.030 |
Why?
| Animals | 2 | 2022 | 14384 | 0.030 |
Why?
| Eating | 1 | 2015 | 155 | 0.030 |
Why?
| Refraction, Ocular | 1 | 2014 | 9 | 0.030 |
Why?
| Infant | 2 | 2013 | 3816 | 0.030 |
Why?
| Valsalva Maneuver | 1 | 2013 | 7 | 0.030 |
Why?
| Posture | 1 | 2013 | 79 | 0.030 |
Why?
| Regression Analysis | 1 | 2013 | 445 | 0.030 |
Why?
| Brain | 1 | 2021 | 1387 | 0.030 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 142 | 0.030 |
Why?
| Lipoproteins, HDL | 1 | 2011 | 21 | 0.030 |
Why?
| Heart Rate | 1 | 2013 | 357 | 0.030 |
Why?
| Diastole | 1 | 2010 | 79 | 0.020 |
Why?
| Systole | 1 | 2010 | 80 | 0.020 |
Why?
| Child, Preschool | 1 | 2013 | 4146 | 0.020 |
Why?
| Treatment Outcome | 1 | 2013 | 5604 | 0.010 |
Why?
|
|
Park's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|